Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDPK1 | O15530 | 1/20 | 0.54 |
| ▸ | GDA | Q9Y2T3 | 1/20 | 0.54 |
| ▸ | PI4KA | P42356 | 2/20 | 0.43 |
| ▸ | PI4K2B | Q8TCG2 | 2/20 | 0.43 |
| ▸ | PI4K2A | Q9BTU6 | 2/20 | 0.43 |
| ▸ | PI4KB | Q9UBF8 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | DRD3 | P35462 | 1/20 | 0.43 |
| ▸ | XDH | P47989 | 1/20 | 0.43 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.43 |
| ▸ | POLA1 | P09884 | 2/20 | 0.43 |
| ▸ | CDK2 | P24941 | 6/20 | 0.40 |
| ▸ | DPP4 | P27487 | 1/20 | 0.40 |
| ▸ | CDK1 | P06493 | 6/20 | 0.39 |
| ▸ | CCNB1 | P14635 | 6/20 | 0.39 |
| ▸ | CCNA2 | P20248 | 5/20 | 0.39 |
| ▸ | CCNA1 | P78396 | 5/20 | 0.39 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.39 |
| ▸ | PNP | P00491 | 1/20 | 0.39 |
| ▸ | KDR | P35968 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL67130 | 1.00 | PDPK1 (0.54) | PDPK1GDAPI4KAPI4K2BPI4K2A | |
| SCHEMBL1374742 | 0.94 | PDPK1 (0.51) | PDPK1GDAPI4KAPI4K2BPI4K2A | |
| SCHEMBL38912 | 0.94 | PDPK1 (0.51) | PDPK1GDAPI4KAPI4K2BPI4K2A | |
| SCHEMBL29808400 | 0.94 | PDPK1 (0.51) | PDPK1GDAPI4KAPI4K2BPI4K2A | |
| SCHEMBL6379588 | 0.90 | PDPK1 (0.58) | PDPK1GDAPI4KAPI4K2BPI4K2A | |
| SCHEMBL11222102 | 0.88 | PDPK1 (0.63) | PDPK1GDAPI4KAPI4K2BPI4K2A | |
| SCHEMBL19746433 | 0.86 | PDPK1 (0.53) | PDPK1GDAPI4KAPI4K2BPI4K2A | |
| SCHEMBL8537687 | 0.86 | PDPK1 (0.53) | PDPK1GDAPI4KAPI4K2BPI4K2A | |
| SCHEMBL27128261 | 0.86 | PDPK1 (0.53) | PDPK1GDAPI4KAPI4K2BPI4K2A | |
| SCHEMBL1074970 | 0.86 | POLA1 (0.57) | PDPK1GDAPI4KAPI4K2BPI4K2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122095092-A | Inhibitor for inhibiting inhibin Beta E gene expression and application thereof | — | 2026-05-26 | — | — | CN | disclosed |
| CN-122095091-A | DsRNA for inhibiting LPA gene expression and application thereof | — | 2026-05-26 | — | — | CN | disclosed |
| EP-4689071-A2 | MRNA THERAPEUTICS FOR OOCYTE MATURATION | Eastern Virginia Medical School (US) | 2026-02-11 | — | — | EP | disclosed |
| EP-4637812-A1 | HEPATITIS B COMPOSITIONS | GlaxoSmithKline Biologicals S.A. (BE) | 2025-10-29 | — | — | EP | disclosed |
| EP-4604933-A1 | METHODS AND USES ASSOCIATED WITH LIQUID COMPOSITIONS | BioNTech SE (DE) | 2025-08-27 | — | — | EP | disclosed |
| EP-4569112-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING AT ALTERNATIVE SPLICE SITES | Remix Therapeutics Inc. (US) | 2025-06-18 | — | — | EP | disclosed |
| CN-120153078-A | RNA molecules encoding RSV-F and vaccines containing the same | 辉瑞大药厂 | 2025-06-13 | — | — | CN | disclosed |
| CN-120077130-A | Universal non-targeted SIRNA compositions and methods of use thereof | 阿尔尼拉姆医药品有限公司 | 2025-05-30 | — | — | CN | disclosed |
| EP-4554617-A1 | NOROVIRUS MRNA VACCINES | ModernaTX, Inc. (US) | 2025-05-21 | — | — | EP | disclosed |
| WO-2025096203-A1 | TARGETING A CHIMERIC RNA FOR TREATING CANCER | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2025-05-08 | — | — | WO | disclosed |
| EP-4090664-A1 | REAGENTS AND THEIR USE FOR MODULAR ENANTIODIVERGENT SYNTHESIS OF C-P BONDS | Bristol-Myers Squibb Company (US) | 2022-11-23 | — | — | EP | disclosed |
| CN-115244061-A | Reagents and their use for modular enantioselective synthesis of C-P bonds | 百时美施贵宝公司 | 2022-10-25 | — | — | CN | disclosed |
| CN-115176027-A | Compositions and methods for light-directed biomolecular barcoding | 哈佛大学校长及研究员协会 | 2022-10-11 | — | — | CN | disclosed |
| WO-2022212191-A1 | MUCOSAL EXPRESSION OF ANTIBODY STRUCTURES AND ISOTYPES BY MRNA | MODERNATX, INC. (US) | 2022-10-06 | — | — | WO | disclosed |
| CN-115038790-A | Synthesis of 3' -RNA oligonucleotides | 阿尔尼拉姆医药品有限公司 | 2022-09-09 | — | — | CN | disclosed |
| CN-114945669-A | Extrahepatic delivery | 阿尔尼拉姆医药品有限公司 | 2022-08-26 | — | — | CN | disclosed |
| CN-109640962-B | Polynucleotides encoding relaxin | 摩登纳特斯有限公司 | 2022-07-19 | — | — | CN | disclosed |
| WO-2022122689-A1 | RNA MANUFACTURING | BioNTech SE (DE) | 2022-06-16 | — | — | WO | disclosed |
| CN-114404581-A | Cancer vaccine | 摩登纳特斯有限公司 | 2022-04-29 | — | — | CN | disclosed |
| WO-2022051677-A1 | COMPOSITIONS AND METHODS FOR CAPPING RNAS | VERVE THERAPEUTICS, INC. (US) | 2022-03-10 | — | — | WO | disclosed |